The British authorities classify Astrazeneca's corona vaccine as safe, despite rare thrombosis cases.
The Netherlands is temporarily stopping Astrazeneca vaccinations.
In Great Britain there have been 30 cases of thrombosis after an Astrazeneca vaccination *.
(see first report)
The British authorities continue to classify the corona vaccine *, which is now marketed in the EU under "Vaxzevria", as safe and efficient in the fight against Covid-19 *.
(see first report)
In the Netherlands *, the Astrazeneca vaccination was temporarily stopped on Saturday.
(see update from April 3, 4.30 p.m.)
This news ticker is updated regularly.
Update from April 3, 4.30 p.m.:
The Netherlands have temporarily stopped vaccination with the preparation from the manufacturer Astrazeneca.
First of all, the Ministry of Health decided on Friday evening not to vaccinate people under the age of 60 with the Astrazeneca vaccine.
The reason for the provisional vaccination stop were five reports of thrombosis in women between the ages of 25 and 65 years after vaccination.
One person died.
According to the authorities, it is still being investigated whether there is a connection with the vaccination.
On Saturday, after consulting the ministry, the health authorities decided to suspend all Astrazeneca vaccinations to prevent waste.
Around 700 people in the age group over 60 should be vaccinated with Astrazeneca in the next few days.
Since it could not be guaranteed that a few people at each vaccination center could actually use the entire vaccine from one ampoule, these appointments were temporarily canceled.
The vaccination stop is to apply until April 7th.
So far, around 400,000 people in the Netherlands have been vaccinated with Astrazeneca.
Corona vaccine: British authority positions itself to Astrazeneca - "Benefits outweigh risks"
Update from April 3, 1:19 p.m
.: Shortly after the MHRA spoke of a "very low" risk
(see initial
report
below),
bad news.
In the UK, seven people have so far died of blood clots after an Astrazeneca corona vaccination.
The British health authority announced on Saturday to the
AFP
news
agency
.
The investigations into the thrombosis cases continued, it said.
Our first report from April 3rd
: London - According to the health authorities, 30 cases of dangerous blood clots have been registered in Great Britain after more than 18 million Astrazeneca vaccinations across the country.
The risk of such a disease is "very low", said the British Medicines Agency (MHRA) on Friday.
"The benefits of vaccination continue to outweigh the risks."
France * reported two more deaths after vaccinations with Astrazeneca.
In the Netherlands, the vaccine is no longer used for the time being.
The British-Swedish pharmaceutical company Astrazeneca will market its coronavirus vaccine in the EU under the name Vaxzevria.
Corona vaccination from Astrazeneca (Vaxzevria): France reports three new cases of thrombosis
The MHRA called on all Brits to continue vaccinating.
Vaccination is the only efficient way to avoid deaths and serious illnesses due to corona infection, the authority emphasized.
The French authorities reported three new cases of dangerous blood clots and two deaths after Astrazeneca vaccinations on Friday.
A total of twelve cases and four deaths have now been recorded in connection with the administration of the vaccine, explained the drug authority ANSM.
She also emphasized that the risk of blood clots is very low.
Corona vaccine recommendation: In the case of Astrazeneca, the Netherlands decide like Germany
Like Germany before, the Netherlands decided on Friday not to vaccinate people under the age of 60 with the Astrazeneca (Vaxzevria) vaccine for the time being.
Health Minister Hugo de Jonge announced that five new cases of dangerous blood clots had been reported.
Women between the ages of 25 and 65 are affected, and one of them has died.
The minister also stressed that it was a precautionary measure.
This should apply until a new opinion of the European Medicines Agency (EMA) on this subject, which is expected on April 7th.
Around 10,000 vaccinations planned for next week for health care workers under the age of 60 would now be suspended.
The federal government decided on Tuesday to inoculate the Astrazeneca vaccine only on people over 60 years of age.
The background to this is thrombosis, particularly among younger women.
(AFP / frs) * Merkur.de is an offer from IPPEN.MEDIA